Skip to Content
MilliporeSigma
HomeServicesTestingRaw Material Testing

Raw Material Testing

We offer a wide range of test services to ensure raw material quality and purity in cell banks, seed viruses, and finished products

Use of animal-derived products in biologics development or manufacturing creates an inherent risk of adventitious agent contamination in historic cell banks, seed viruses, and finished products. We offer a wide range of testing services aimed at ensuring the quality and purity of your raw materials, including:

  • Sterility testing
  • Mycoplasma detection assays
  • Adventitious virus testing/virology testing
  • Residual DNA testing
  • Endotoxin detection, LAL test
  • Bioburden testing
  • Bovine and porcine raw materials
  • Next Generation Sequencing

To discuss your raw material testing needs with an expert, use our reply form and get in touch today.

Related Product Resources

Application Note: Cell and Gene Therapy Definitions for Raw Materials, Starting Materials, Drug Substance and Drug Product
Poster: Mitigating the Risk of Zika Virus Contamination of Raw Materials & Vaccines by In Vitro Assays
Poster: An in vitro assay for detection of adventitious viruses of Ovine and Caprine origin in raw materials used in the production of biopharmaceuticals for use in humans

Request Information

Related Services
Bulk Harvest Release Testing
Whether you’re preparing for first-in-human clinical trials or scaling up for global distribution of a life-changing therapeutic biologic, our cGMP-compliant bulk harvest release testing services protect your investment at every step.
Final Product Release Testing
With all biologics released into global pharmaceutical markets requiring GMP testing of final product, we offer a wide range of assays and lot release testing services to help you demonstrate compliance with regulatory guidelines.
Related Applications
Monoclonal Antibody Manufacturing
Monoclonal antibody manufacturing requires scalable solutions ensuring high therapeutic concentration and process safety for immunotherapy.
Gene Therapy Manufacturing
Gene therapy innovation requires integrated manufacturing, testing, safety, and compliance expertise from experienced partners.
Cell Therapy Manufacturing
Introducing a new cell therapy demands optimal performance in upstream and downstream processing, process development, testing, and manufacturing. World-class products and partners are critical to success, speeding advancement of therapeutics that are effective, safe, and affordable.
Vaccine Manufacturing
From early phase development, through downstream purification to large scale vaccine production: learn more about vaccine process development and application expertise.
Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?